As shown in Fig. 1A, ERO1A-Q4 was associated with poor prognosis across all NSCLC samples, with a median OS = 14.61 m (vs ERO1A-Q1 median OS = 23.524 m, HR = 1.381, p < 0.00001). The gene discussed is ERO1A; the disease is non-small cell lung carcinoma.